Search Orphan Drug Designations and Approvals
-
Generic Name: | mRNA encoding human ornithine transcarbamylase |
---|---|
Date Designated: | 11/23/2016 |
Orphan Designation: | Treatment of ornithine transcarbamylase deficiency |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
PhaseRx, Inc. 410 West Harrison Street Suite 300 Seattle, Washington 98119 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-